EUVIMEDEUVIMED entdecken
Crossref

E7 peptide for in situ tissue engineering applications in bone repair

Wentao Zhang, Kaizhong Wang, Moran Suo, Xiangyan Liu, Jinzuo Wang, Xin Liu, Huagui Huang, Shuang Chen, Hui Wang, Xin Chen, Zhonghai Li

Journal of the American Ceramic Society · 2025-11 · 108 (11)

DOI: 10.1111/jace.20524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Ceramic Society, 2025-04. Verfasst von Wentao Zhang und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In regenerative medicine, leveraging bioactive molecules to enhance endogenous repair mechanisms represents a critical advancement. The E7 peptide, a novel short peptide, has emerged as a key candidate for bone defect repair due to its unique ability to interact with stem cells directly. Unlike traditional tissue‐engineered bone constructs that rely on exogenous cell delivery or scaffold‐based strategies, E7 enables in situ regeneration by actively recruiting and anchoring endogenous stem cells to the defect site. Studies demonstrate that E7‐functionalized materials significantly enhance stem cell proliferation and osteogenic differentiation while concurrently stimulating local angiogenesis through VEGF upregulation. These dual effects—stem cell homing and vascularization—address two major bottlenecks in bone repair: insufficient cell supply and poor nutrient diffusion in avascular regions. Despite these advantages, optimizing E7's spatiotemporal presentation and elucidating its signaling mechanisms remain critical. Further investigations into E7's receptor specificity, dose dependency, and long‐term safety will accelerate its clinical translation. It is of great guiding significance to clarify what role. E7 peptide plays in various bone repair materials and which pathways are activated for future research of bone defect repair.

Zitieren

APA

Zhang, W., Wang, K., Suo, M., Liu, X., Wang, J., Liu, X., Huang, H., Chen, S., Wang, H., Chen, X., & Li, Z. (2025). E7 peptide for in situ tissue engineering applications in bone repair. Journal of the American Ceramic Society, 108(11). https://doi.org/10.1111/jace.20524

Vancouver

Zhang W, Wang K, Suo M, Liu X, Wang J, Liu X, et al. E7 peptide for in situ tissue engineering applications in bone repair. Journal of the American Ceramic Society. 2025;108(11). doi:10.1111/jace.20524

BibTeX
@article{Zhang2025,
  author = {Zhang, Wentao and Wang, Kaizhong and Suo, Moran and Liu, Xiangyan and Wang, Jinzuo and Liu, Xin and Huang, Huagui and Chen, Shuang and Wang, Hui and Chen, Xin and Li, Zhonghai},
  title = {E7 peptide for in situ tissue engineering applications in bone repair},
  journal = {Journal of the American Ceramic Society},
  year = {2025},
  volume = {108},
  number = {11},
  doi = {10.1111/jace.20524}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche